Paper

The use of bacitracin as an inhibitor of the degradation of thyrotropin releasing factor and luteinizing hormone releasing factor.

Published Nov 22, 1976 · J. McKelvy, P. Leblanc, C. Laudes

Biochemical and biophysical research communications

130

Citations

Influential Citations

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

In Vitro StudyHighly Cited

Study Snapshot

Bacitracin effectively inhibits the degradation of thyrotropin releasing factor 1 and luteinizing hormone releasing factor in vitro, without degrading itself during in vitro incubation.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

The use of bacitracin as an inhibitor of the degradation of thyrotropin releasing factor and luteinizing hormone releasing factor.

References

Citations